References
Chen W, Gluud C. Bile acids for primary sclerosing cholangitis. Cochrane Database Syst Rev 2003; CD003626
Chen W, Gluud C. Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst Rev 2004; CD004036
K Kozaiwa H Tajiri A Sawada K Tada Y Etani K Miki S Okada (1998) ArticleTitleThree paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine J Gastroenterol Hepatol 13 825–9 Occurrence Handle9736177 Occurrence Handle1:STN:280:DyaK1cvgsFGrtg%3D%3D
MA Peppercorn P Goldman (1972) ArticleTitleThe role of intestinal bacteria in the metabolism of salicylazosulfapyridine J Pharmacol Exp Ther 181 555 Occurrence Handle4402374 Occurrence Handle1:CAS:528:DyaE38Xks12qt7c%3D
C Stevens M Lipman S Fabry M Moscovitch-Lopatin W Almawi S Keresztes et al. (1995) ArticleTitle5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells J Pharmacol Exp Ther 272 399–406 Occurrence Handle7815356 Occurrence Handle1:CAS:528:DyaK2MXjtFSqtb8%3D
I Ahnfelt-Ronne OH Nielsen A Christensen E Langholz V Binder P Riis (1990) ArticleTitleClinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid Gastroenterology 98 1162–9 Occurrence Handle1969825 Occurrence Handle1:STN:280:By%2BB3MrgvFc%3D
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tada, S., Ebinuma, H., Saito, H. et al. Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis. J Gastroenterol 41, 388–389 (2006). https://doi.org/10.1007/s00535-005-1758-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00535-005-1758-x